NDC 25682-025 – Ultomiris
Ravulizumab 300 mg/3mL · Solution, Concentrate · Intravenous
Product NDC25682-025
Product details
- Brand name
- Ultomiris
- Generic name
- Ravulizumab
- Labeler
- Alexion Pharmaceuticals Inc.
- Dosage form
- Solution, Concentrate
- Route
- Intravenous
- Marketing category
- BLA · BLA761108
- Marketed since
- October 9, 2020
- Listing expires
- December 31, 2026
- Pharmacologic class
- Complement Inhibitor
Active ingredients
- Ravulizumab 300 mg/3mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 25682-025-01 | 1 VIAL, GLASS in 1 CARTON (25682-025-01) / 3 mL in 1 VIAL, GLASS | Oct 9, 2020 |